Trial Profile
Comparison of acid inhibition attained by esomeprazole and vonoprazan with reference to CYP2C19 genotypes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Vonoprazan (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Reflux oesophagitis
- Focus Pharmacodynamics
- 03 Dec 2015 Number of treatment arms changed from 4 to 10 as reported by University Hospital Medical Information Network - Japan record.
- 27 Nov 2015 New trial record